(IN BRIEF) AstraZeneca and Sanofi celebrate the approval of Beyfortus (nirsevimab) in Japan by the Ministry of Health, Labour, and Welfare for preventing lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in neonates, infants, and children entering … Read the full press release
Posted in Business, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, Beyfortus, Dr. Hiroyuki Moriuchi, France, Iskra Reic, Japan, LRTD, partnership, prophylaxis, respiratory syncytial virus, safety, Sanofi, sustainability
The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment Prophylactic treatment aims to prevent bleeds and allow people with haemophilia to achieve quality of life … Read the full press release
Posted in Healthcare, Non Profit, Pharma & Biotech, Switzerland
Tagged acute bleeds, Bill Anderson, bleeding disorders, Cesar Garrido, Chugai, Dr Osamu Okuda, Haemophilia A, Humanitarian Aid Program, prophylactic treatment, prophylaxis, Roche, WFH Humanitarian Aid Program, World Federation of Hemophilia
El compromiso renovado proporcionará tratamiento preventivo (profiláctico) continuo a hasta 1000 personas con hemofilia A en lugares donde hay poco o ningún acceso al tratamiento de la hemofilia. El tratamiento profiláctico tiene como objetivo prevenir las hemorragias y permitir que las personas … Read the full press release
Posted in News
Tagged acute bleeds, Bill Anderson, bleeding disorders, Cesar Garrido, Chugai, Dr Osamu Okuda, Dr. Osamu Okuda, Federación Mundial de Hemofilia, Haemophilia A, hemofilia A, hemorragias agudas, Humanitarian Aid Program, profilaxis, Programa de ayuda humanitaria, Programa de ayuda humanitaria de la FMH, prophylactic treatment, prophylaxis, Roche, trastornos hemorrágicos, tratamiento profiláctico, WFH Humanitarian Aid Program, World Federation of Hemophilia
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?